Digital PET/CT Technology to Provide Improved Image Quality
By MedImaging International staff writers Posted on 05 Jan 2016 |
A new generation of PET/CT scanners could lead to improved patient care according to a study presented at the annual Radiological Society of North America (RSNA 2015) meeting in Chicago (IL, USA).
The new systems Positron Emission Tomography/Computed Tomography (PET/CT) technology uses solid-state components, and all-digital data, and provides a dramatic reduction in the tracer dose for clinical PET imaging. Other advantages of the new technology include improved accuracy and visual/quantitative quality, and improved reproducibility of measurements for PET imaging in clinical oncology.
In the Phase 1 study, blinded readers compared images made using current generation photomultiplier tubes with images scanned using Royal Philips Healthcare (Amsterdam, The Netherlands) Vereos 64 TF scanners in which the tubes were replaced by a solid-state digital photon counting chip. The readers reported higher confidence in the detection and delineation of lesions on scans of 30 patients with various malignant tumors, using the new scanners.
The new end-to-end digital solid state scanners dramatically improve image reconstruction capabilities compared to existing scanners, and temporal resolution is improved from 500 picoseconds to 325 picoseconds. Very high resolution reconstruction is possible with new scanners, without compromising image quality, and a slice thickness as thin as 1–2 mm. According to the study, the new scanners can use half the radiation dose of current technology, without any impact on quality and detectability.
Dr. Knopp, director, Wright Center for Innovation and Biomedical Imaging, Ohio State University "The system and the technology have performed remarkably well. It allows us to visualize with a higher definition and higher reconstruction maintenance, which can translate into better lesion detectability and quantitative accuracy. Also, confidence of lesion detectability was rated significantly higher on the digital PET when evaluating lesions of less than 15 mm. This research demonstrates that the new generation of PET scanners can be used as a better clinical tool or biomarker, especially for today's targeted therapeutics. The images look crisper and more precise and provide a truer metabolic coefficient ratio. This technology can redefine our clinical work, especially with some of the exciting new tracer doses on the horizon."
Related Links:
Philips Healthcare
The new systems Positron Emission Tomography/Computed Tomography (PET/CT) technology uses solid-state components, and all-digital data, and provides a dramatic reduction in the tracer dose for clinical PET imaging. Other advantages of the new technology include improved accuracy and visual/quantitative quality, and improved reproducibility of measurements for PET imaging in clinical oncology.
In the Phase 1 study, blinded readers compared images made using current generation photomultiplier tubes with images scanned using Royal Philips Healthcare (Amsterdam, The Netherlands) Vereos 64 TF scanners in which the tubes were replaced by a solid-state digital photon counting chip. The readers reported higher confidence in the detection and delineation of lesions on scans of 30 patients with various malignant tumors, using the new scanners.
The new end-to-end digital solid state scanners dramatically improve image reconstruction capabilities compared to existing scanners, and temporal resolution is improved from 500 picoseconds to 325 picoseconds. Very high resolution reconstruction is possible with new scanners, without compromising image quality, and a slice thickness as thin as 1–2 mm. According to the study, the new scanners can use half the radiation dose of current technology, without any impact on quality and detectability.
Dr. Knopp, director, Wright Center for Innovation and Biomedical Imaging, Ohio State University "The system and the technology have performed remarkably well. It allows us to visualize with a higher definition and higher reconstruction maintenance, which can translate into better lesion detectability and quantitative accuracy. Also, confidence of lesion detectability was rated significantly higher on the digital PET when evaluating lesions of less than 15 mm. This research demonstrates that the new generation of PET scanners can be used as a better clinical tool or biomarker, especially for today's targeted therapeutics. The images look crisper and more precise and provide a truer metabolic coefficient ratio. This technology can redefine our clinical work, especially with some of the exciting new tracer doses on the horizon."
Related Links:
Philips Healthcare
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment